Compare TENB & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TENB | TMDX |
|---|---|---|
| Founded | 2002 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.6B |
| IPO Year | 2018 | 2019 |
| Metric | TENB | TMDX |
|---|---|---|
| Price | $41.92 | $72.00 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 23 | 13 |
| Target Price | $35.50 | ★ $98.73 |
| AVG Volume (30 Days) | ★ 3.1M | 713.8K |
| Earning Date | 10-28-2026 | 11-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 3.23 | ★ 382.18 |
| EPS | 0.05 | ★ 0.61 |
| Revenue | ★ $999,405,000.00 | $605,494,000.00 |
| Revenue This Year | $7.94 | $22.57 |
| Revenue Next Year | $7.12 | $17.85 |
| P/E Ratio | $811.60 | ★ $119.75 |
| Revenue Growth | 11.04 | ★ 37.13 |
| 52 Week Low | $15.73 | $60.11 |
| 52 Week High | $43.67 | $156.00 |
| Indicator | TENB | TMDX |
|---|---|---|
| Relative Strength Index (RSI) | 61.30 | 36.32 |
| Support Level | $31.48 | $66.64 |
| Resistance Level | $43.18 | $79.60 |
| Average True Range (ATR) | 2.15 | 3.93 |
| MACD | 0.13 | -0.62 |
| Stochastic Oscillator | 83.55 | 26.43 |
Founded in 2002, Tenable is a cybersecurity company that began providing vulnerability management solutions under its Nessus software. In recent years, Tenable has expanded its portfolio to provide a broader range of exposure management modules. Solutions include cloud security and compliance, active directory management, operational technology security and advanced vulnerability analytics. The Maryland-based company went public in 2018.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.